Citations to this article

Immune system versus tumor: shifting the balance in favor of DCs and effective immunity
Howard L. Kaufman, Mary L. Disis
Howard L. Kaufman, Mary L. Disis
Published March 1, 2004
Citation Information: J Clin Invest. 2004;113(5):664-667. https://doi.org/10.1172/JCI21148.
View: Text | PDF
Commentary Article has an altmetric score of 3

Immune system versus tumor: shifting the balance in favor of DCs and effective immunity

Abstract

Despite the initial excitement over cancer vaccines, the clinical effectiveness of immunotherapy has been disappointing. The suppressive milieu present within established tumors inhibits effective immune responses, although new strategies are emerging to manipulate the local tumor microenvironment and shift the balance back to a proinflammatory environment, promote DC activation, and enhance tumor immunity .

Authors

Howard L. Kaufman, Mary L. Disis

×

Total citations by year

Year: 2024 2021 2020 2019 2017 2015 2014 2013 2012 2010 2009 2008 2006 2005 Total
Citations: 1 1 1 1 2 1 1 1 2 1 2 2 1 1 18
Citation information

Citations to this article (18)

Title and authors Publication Year
Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives
Levstek L, Janžič L, Ihan A, Kopitar AN 		Frontiers in immunology 2024
Polysaccharide Isolated From Tetrastigma hemsleyanum Activates TLR4 in Macrophage Cell Lines and Enhances Immune Responses in OVA-Immunized and LLC-Bearing Mouse Models
Zhou FM, Chen YC, Jin CY, Qian CD, Zhu BQ, Zhou Y, Ding ZS, Wang YQ 		Frontiers in pharmacology 2021
Differential gene expression of tumor-infiltrating CD33+ myeloid cells in advanced- versus early-stage colorectal cancer
SM Toor, RZ Taha, VS Nair, R Saleh, K Murshed, MA Nada, E Elkord 		Cancer Immunology, Immunotherapy 2020
Antitumor immunity of low-dose cyclophosphamide: changes in T cells and cytokines TGF-beta and IL-10 in mice with colon-cancer liver metastasis
XM Huang, NR Zhang, XT Lin, CY Zhu, YF Zou, XJ Wu, XS He, XW He, YL Wan, P Lan 		Gastroenterology Report 2019
Rehmannia glutinosa polysaccharide induces toll-like receptor 4 dependent spleen dendritic cell maturation and anti-cancer immunity
Xu L, Kwak M, Zhang W, Zeng L, Lee PC, Jin JO 		OncoImmunology 2017
Laminarin promotes anti-cancer immunity by the maturation of dendritic cells
Song K, Xu L, Zhang W, Cai Y, Jang B, Oh J, Jin JO 		Oncotarget 2017
Engineering cancer microenvironments for in vitro 3-D tumor models
Asghar W, El Assal R, Shafiee H, Pitteri S, Paulmurugan R, Demirci U 		Materials today (Kidlington, England) 2015
CCL21 and IFNγ recruit and activate tumor specific T cells in 3D scaffold model of breast cancer.
Phan-Lai V, Kievit FM, Florczyk SJ, Wang K, Disis ML, Zhang M 		Anti-cancer agents in medicinal chemistry 2014
Current concepts in clinical radiation oncology
M Orth, K Lauber, M Niyazi, AA Friedl, M Li, C Maihöfer, L Schüttrumpf, A Ernst, OM Niemöller, C Belka 		Biophysik 2013
Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy
Yeung JT, Hamilton RL, Okada H, Jakacki RI, Pollack IF 		Journal of Neuro-Oncology 2012
Effective modulation of CD4+CD25+high regulatory T and NK cells in malignant patients by combination of interferon-α and interleukin-2
Liu G, Yang W, Guo M, Liu X, Huang N, Li D, Jiang Z, Yang W, Zhang W, Su H, Liu Z, Liu T, Wang D, Huang S, Yao B, Man Q, Qiu L, Sun X, Sun Y, Liu B 		Cancer Immunology, Immunotherapy 2012
Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression
O Radkevich-Brown, MP Piechocki, JB Back, AM Weise, S Pilon-Thomas, WZ Wei 		Cancer Immunology, Immunotherapy 2010
Use of tumour-responsive T cells as cancer treatment
ML Disis, H Bernhard, EM Jaffee 		Lancet 2009
Targeting the Intratumoral Dendritic Cells by the Oncolytic Adenoviral Vaccine Expressing RANTES Elicits Potent Antitumor Immunity:
N Lapteva, M Aldrich, D Weksberg, L Rollins, T Goltsova, SY Chen, XF Huang 		Journal of immunotherapy (Hagerstown, Md. : 1997) 2009
MHCII Vaccines Activate Lung Cancer Patients' CD4+ T Cells Despite the Presence of Myeloid-Derived Suppressor Cells
Minu K. Srivastava, Jacobus J. Bosch, James A. Thompson, Bruce R. Ksander, Martin J. Edelman, Suzanne Ostrand-Rosenberg 		2008
Development of a swine model of secondary liver tumor from a genetically induced swine fibroblast cell line
R Abbas, SJ Adam, S Okadal, H Groar, J Anderson, J Sanabria 		HPB : the official journal of the International Hepato Pancreato Biliary Association 2008
Dendritic cell infiltration and prognosis of human hepatocellular carcinoma.
Cai XY, Gao Q, Qiu SJ, Ye SL, Wu ZQ, Fan J, Tang ZY 		Journal of Cancer Research and Clinical Oncology 2006
Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance.
Ferris RL, Hunt JL, Ferrone S 		Immunologic research 2005

Advertisement